Testing effectiveness (Phase 2)UnknownNCT05050630
What this trial is testing
Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL
Who this might be right for
Age Range ≥16 Years, Gender UnlimitedHistopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell LymphomaReceived Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed+4 more
Affiliated Hospital to Academy of Military Medical Sciences 73